Working… Menu

Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord (MSC-SLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03562065
Recruitment Status : Recruiting
First Posted : June 19, 2018
Last Update Posted : July 8, 2021
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 1, 2023
Estimated Study Completion Date : June 1, 2024